The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Differential diagnosis of elevated troponins
Open accessAbstract
n the year 2000, the European Society of Cardiology and the American College of Cardiology Committee jointly redefined myocardial infarction (MI) by an elevation of cardiac troponin T (cTnT) or I (cTnI) in conjunction with clinical evidence of myocardial ischaemia. 1Since then, cTnT and cTnI have replaced creatine kinase-MB (CK-MB) as the preferred biochemical markers for the diagnosis of MI.The decision for including cardiac troponins (cTn) in the diagnostic pathway was made because of the high sensitivity of cTn for detection of even small amounts of myocardial necrosis.An elevation of cTn indicates the presence of, but not the underlying reason for, myocardial injury.Hence, besides acute myocardial infarction (AMI), there is a myriad of potential diseases with troponin release, including acute pulmonary embolism, heart failure, myocarditis, and end stage renal disease.But regardless of what the release mechanism into the blood from cardiac myocytes is, elevated cTnT and cTnI almost always imply a poor prognosis.This article attempts to highlight the differential diagnosis of elevated cTn according to the various aetiologies of myocyte damage (table 1). WHAT ARE CARDIAC TROPONINS? cThe troponin complex consists of three subunits-troponin C, troponin I, and troponin T-and is located on the myofibrillar thin (actin) filament of striated (skeletal and cardiac) muscle (fig 1).The cardiac isoforms troponin T and I are only expressed in cardiac muscle.Hence, cardiac troponin T (cTnT) and I (cTnI) are more specific than creatine kinase (CK) values for myocardial injury and, because of their high sensitivity, they may even be elevated when CK-MB concentrations are not.The cTn complex regulates excitation-contraction coupling in the heart.Cardiac troponin C (cTnC), a calcium (Ca 2+ ) binding 18-kD-protein, regulates the activation of the actin filaments.cTnI (,23 kD) inhibits contraction in the absence of Ca 2+ binding to cTnC, and cTnT, the greatest subunit (,35 kD), attaches the whole troponin complex to tropomyosin and to the actin filaments. 2cTn are found as structural (bound) proteins and as a small free pool that exists in the cytosol, which is about 6-8% for cTnT and 3.5% for cTnI.In some diseases, and supposedly in the case of pulmonary embolism or after ultra-endurance physical exercise, a transient leakage of the cytosolic pool of cTn, although never proven, cannot be excluded.Following myocardial damage, cTn egress rapidly from the myocyte and will appear in blood after 2-4 hours and persist long enough (up to 10-21 days) for convenient diagnosis.Furthermore, detection of cTn with immunoassays is easy, inexpensive, and the results are readily available, making them ideal biomarkers in most emergency facilities.Table 2 Analytical causes of false-positive troponins c Rhabdomyolysis in first and second generation troponin assays c Heterophilic antibodies c Rheumatoid factor c Fibrin clots c Microparticles c Analyser or analyte malfunction
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Antman, E., Bassand, J.-P., Klein, W., Ohman, M., Lopez Sendon, J. L., Rydén, L., Simoons, M., & Tendera, M. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00804-4 · Cited by 4,821
Zhang, J., & Yu, K. F. (1998) · JAMA · doi:10.1001/jama.280.19.1690 · Cited by 4,138
A strategy to reduce cardiovascular disease by more than 80%
Wald, N. J., & Law, M. R. (2003) · BMJ · doi:10.1136/bmj.326.7404.1419 · Cited by 1,568
beta Blockade after myocardial infarction: systematic review and meta regression analysis
Freemantle, N., Cleland, J., Young, P., Mason, J., & Harrison, J. (1999) · BMJ · doi:10.1136/bmj.318.7200.1730 · Cited by 1,509
Prevention of coronary heart disease in clinical practice
PYÖRÄLÄ, K., BACKER, G. D., GRAHAM, I., POOLE-WILSON, P., & WOOD, D. (1994) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060388 · Cited by 1,163
Davies, H. T. O., Crombie, I. K., & Tavakoli, M. (1998) · BMJ · doi:10.1136/bmj.316.7136.989 · Cited by 984
Gottlieb, S. S., McCarter, R. J., & Vogel, R. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390801 · Cited by 982
Diagnostic efficiency of troponin T measurements in acute myocardial infarction.
Katus, H. A., Remppis, A., Neumann, F. J., Scheffold, T., Diederich, K. W., Vinar, G., Noe, A., Matern, G., & Kuebler, W. (1991) · Circulation · doi:10.1161/01.cir.83.3.902 · Cited by 814
Self-citationSmith, S. C., Blair, S. N., Bonow, R. O., Brass, L. M., Cerqueira, M. D., Dracup, K., Fuster, V., Gotto, A., Grundy, S. M., Miller, N. H., et al. (2001) · Circulation · doi:10.1161/hc3801.097475 · Cited by 661
Predictive Value of Cardiac Troponin I and T for Subsequent Death in End-Stage Renal Disease
Apple, F. S., Murakami, M. M., Pearce, L. A., & Herzog, C. A. (2002) · Circulation · doi:10.1161/01.cir.0000041254.30637.34 · Cited by 559
Independent Prognostic Value of Cardiac Troponin T in Patients With Confirmed Pulmonary Embolism
Giannitsis, E., Müller-Bardorff, M., Kurowski, V., Weidtmann, B., Wiegand, U., Kampmann, M., & Katus, H. A. (2000) · Circulation · doi:10.1161/01.cir.102.2.211 · Cited by 495
Self-citationTroponin T Levels in Patients with Acute Coronary Syndromes, with or without Renal Dysfunction
Aviles, R. J., Askari, A. T., Lindahl, B., Wallentin, L., Jia, G., Ohman, E. M., Mahaffey, K. W., Newby, L. K., Califf, R. M., Simoons, M. L., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013456 · Cited by 345
Oral Anticoagulant Therapy in Patients With Coronary Artery Disease: A Meta-analysis
Anand, S. S. (1999) · JAMA · doi:10.1001/jama.282.21.2058 · Cited by 311
Ottani, F., Galvani, M., Nicolini, F. A., Ferrini, D., Pozzati, A., Di Pasquale, G., & Jaffe, A. S. (2000) · American Heart Journal · doi:10.1067/mhj.2000.111107 · Cited by 257
Biology of the troponin complex in cardiac myocytes
Parmacek, M. S., & Solaro, R. J. (2004) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2004.07.003 · Cited by 212
Herings, R. M., Bakker, A., Stricker, B. H., & Nap, G. (1992) · Journal of Epidemiology and Community Health · doi:10.1136/jech.46.2.136 · Cited by 196
Cardiac troponin I as diagnostic and prognostic marker in severe heart failure
La Vecchia, L., Mezzena, G., Zanolla, L., Paccanaro, M., Varotto, L., Bonanno, C., & Ometto, R. (2000) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(00)00120-0 · Cited by 191
Dagenais, G. R., Yusuf, S., Bourassa, M. G., Yi, Q., Bosch, J., Lonn, E. M., Kouz, S., Grover, J., & on behalf of the HOPE Investigators (2001) · Circulation · doi:10.1161/hc3001.093502 · Cited by 179
Goldbourt, U., Behar, S., Reicher-Reiss, H., Zion, M., Mandelzweig, L., & Kaplinsky, E. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.3.345 · Cited by 173
Hippisley‐Cox, J., & Coupland, C. A. C. (2005) · BMJ · doi:10.1136/bmj.330.7499.1059 · Cited by 142
Plasma levels of cardiac troponin I after prolonged strenuous endurance exercise
Neumayr, G., Gaenzer, H., Pfister, R., Sturm, W., Schwarzacher, S. P., Eibl, G., Mitterbauer, G., & Hoertnagl, H. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01382-5 · Cited by 140
Troponin I elevation and cardiac events after percutaneous coronary intervention
Ricciardi, M. J., Davidson, C. J., Gubernikoff, G., Beohar, N., Eckman, L. J., Parker, M. A., & Bonow, R. O. (2003) · American Heart Journal · doi:10.1067/mhj.2003.2 · Cited by 139
Lehrke, S., Steen, H., Sievers, H. H., Peters, H., Opitz, A., Müller-Bardorff, M., WIEGAND, U. K. H., Katus, H. A., & Giannitsis, E. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.031468 · Cited by 138
Self-citationDokainish, H., Pillai, M., Murphy, S. A., DiBattiste, P. M., Schweiger, M. J., Lotfi, A. S., Morrow, D. A., Cannon, C. P., Braunwald, E., & Lakkis, N. M. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.09.056 · Cited by 127
Comparison of different methods to estimate prevalence of drug use by using pharmacy records
Mantel-Teeuwisse, A. K., Klungel, O. H., Verschuren, W. M. M., Porsius, A. J., & de Boer, A. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00396-1 · Cited by 89
Wu, A. H., & Feng, Y. J. (1998) · PubMed · Cited by 87
Fortnightly review: Secondary prevention in acute myocardial infarction
Mehta, R. H., & Eagle, K. A. (1998) · BMJ · doi:10.1136/bmj.316.7134.838 · Cited by 62
Pericardial disease: what the general cardiologist needs to know
Ivens, E., Munt, B. I., & Moss, R. (2007) · Heart · doi:10.1136/hrt.2005.086587 · Cited by 55
Serum Cardiac Troponins I and T in Early Posttraumatic Rhabdomyolysis
Lavoinne, A., & Hue, G. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.3.667 · Cited by 40
Drug Therapy for Prevention of Recurrent Myocardial Infarction
van der Elst, M. E., Buurma, H., Bouvy, M. L., & de Boer, A. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1c450 · Cited by 26
Efficacy of long-term anticoagulant treatment in subgroups of patients after myocardial infarction.
van Bergen, P. F., Deckers, J. W., Jonker, J. J., van Domburg, R. T., Azar, A. J., & Hofman, A. (1995) · Heart · doi:10.1136/hrt.74.2.117 · Cited by 23
Herings, R. M. C., de Boer, A., Stricker, B. H. C., Bakker, A., & STURMANS, F. (1995) · Pharmacy World & Science · doi:10.1007/bf01875553 · Cited by 20
Effects of long-term anticoagulant therapy in subgroups after acute myocardial infarction.
Smith, P., Arnesen, H., & Abdelnoor, M. (1992) · PubMed · Cited by 18
Dokainish, H., Pillai, M., & Murphy, S. A. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2005.03.005 · Cited by 7
Cited by
Biomarkers in acute myocardial infarction: current perspectives
Aydin, S., Ugur, K., Aydin, S., Sahin, İ., & Yardim, M. (2019) · Vascular Health and Risk Management · doi:10.2147/vhrm.s166157 · Cited by 496
Maus, M. V., Alexander, S., Bishop, M. R., Brudno, J. N., Callahan, C., Davila, M. L., Diamonte, C., Dietrich, J., Fitzgerald, J. C., Frigault, M. J., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001511 · Cited by 282
O’Brien, P. J. (2008) · Toxicology · doi:10.1016/j.tox.2007.12.006 · Cited by 270
Jo, H., Gu, H., Jeon, W., Youn, H., Her, J., Kim, S.-K., Lee, J., Shin, J. H., & Ban, C. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b02312 · Cited by 270
Metadata
- Authors
- Korff, S., Katus, H. A., & Giannitsis, E.
- Venue
- Heart
- Publisher
- BMJ
- Published
- 2006-06-14
- Volume
- 92
- Issue
- 7
- Pages
- 987-993
- ISSN
- 1355-6037 (ISSN-L)
- 1468-201X
- OpenAlex
- W2137271727
- Cited by
- 388
- References
- 37
- FWCI
- 8.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.